FDA Alignment to Advance ProstACT Global Phase 3 Trial

Go back to FDA Alignment to Advance ProstACT Global Phase 3 Trial
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 12.42 +0.30 (2.48%)
Previous Close $12.12    52 Week High $2.18 
Open $12.26    52 Week Low $0.30 
Day High $12.48    P/E N/A 
Day Low $12.06    EPS $-3.32 
Volume 368,571       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 12.42 +0.30 (2.48%)
Previous Close $12.12    52 Week High $2.18 
Open $12.26    52 Week Low $0.30 
Day High $12.48    P/E N/A 
Day Low $12.06    EPS $-3.32 
Volume 368,571